jyongbio.com (MENS): Price to Earnings Adjusted for Growth Rate
Jyong Biotech Ltd (MENS) is advancing plant-based pharmacology within a neutral geopolitical environment, leveraging automated bioscreening and AI modeling. GURU.Markets analytics provide this PEG momentum indicator, where the parameter has settled at 0.00. The business is based on the men's health segment, with the success of Jyong Biotech Ltd (MENS) relying on patent protection and the clinical trial results of new drugs.
Metric breakdowns and analytics for Jyong Biotech Ltd (MENS)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- shareholders' equity book value data:
- business debt structure and liquidity details:
- earnings and market ratios statistics:
MENS - Company Net Income|Net Profit Forecast Jyong Biotech Ltd|MENS - P/E Multiple|Forward Price to Earnings Multiple Jyong Bio|MENS - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Jyong Biotech Corp|MENS - Operating profit EBITDA|Earnings per share for the last twelve months Jyong Biotech|MENS - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months jyongbio.com|MENS - Earnings per share growth in current year|Expected net earnings per share growth next year Jyong Biotech Ltd
- issuer revenue and sales details:
Fundamental company analysis:Jyong Biotech Limited
The PEG ratio correlates the current P/E ratio with the earnings growth rate, identifying undervalued assets with high expansion potential when the value falls below one. By analyzing the peg_co multiplier, an investor can assess the market value of Jyong Biotech Ltd (MENS) through the lens of future MCS-2 drug sales, determining the efficiency of investments in the commercialization of phytopharmaceuticals relative to the pace of business recovery.
Who Jyong Biotech Ltd competes with
HLN (Haleon PLC) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Kenvue Corp KVUE|Verona Pharma Inc. (VRNA) - Price to Earnings Adjusted for Growth Rate|LGND: Price/Earnings to Growth Multiple|amneal.com - Company Value to Earnings Growth Ratio|PRGO: PEG Multiple|Alvotech S.A. - Growth-Adjusted Payback Ratio|LQDA (Liquidia Technologies) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Galapagos Corp GLPG|Price/Earnings to Growth Ratio ANI Pharmaceuticals (ANIP)|MNKD (mannkindcorp.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Amphastar Pharmaceuticals, Inc. AMPH|Company Value to Earnings Growth Ratio PCRX (Pacira Pharmaceuticals)|SPRY: Price/Earnings to Growth Multiple|Price to Earnings Adjusted for Growth Rate Theravance Corp|Aquestive Therapeutics (AQST) - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate scPharmaceuticals (SCPH)|Price/Earnings to Growth Ratio Tectonic Therapeutic Inc.|Growth-Adjusted P/E Ratio TNXP (Tonix Pharma)|PEG Multiple SXTC|eupraxiapharma.com (EPRX) - Price to Net Income Growth Ratio|BioHarvest Sciences - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio EXOZ|Oramed Pharma - PEG Multiple|ENTX: Price/Earnings to Growth Ratio|HYFT: PEG Multiple|ABVC - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Cumberland Pharmaceuticals|Price to Earnings Adjusted for Growth Rate quantumbiopharma.com QNTM|Price/Earnings to Growth Multiple FGEN (FibroGen)|Company Value to Earnings Growth Ratio TELO|PEG Multiple RANI (Rani Therapeutics Holdings, Inc.)|Synergy CHC Corp. (SNYR) - Price to Earnings Adjusted for Growth Rate|Rallybio Corp. - PEG Multiple|Lexaria Bioscience (LEXX) - Price/Earnings to Growth Multiple|PULM: PEG Multiple|Pheton Holdings - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Multiple APM|LYRA: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Impact BioMedical Inc (IBO)|Price/Earnings to Growth Ratio TNFA (tnfpharma.com)|cbdMD - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio PRFX (PainReform Ltd)|Auris Medical - PEG Multiple|LIPO (Lipella Pharma) - Growth-Adjusted P/E Ratio|OptiNose, Inc. (OPTN) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple pieris.com|PROC (Procaps) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Petros Pharmaceuticals Inc PTPI|Price/Earnings to Growth Ratio Qilian International Holding Group Limited (QLI)|ACELYRIN Inc. - Growth-Adjusted P/E Ratio|Price/Earnings to Growth Ratio TFF Pharmaceuticals TFFP
